3 Followers on Owler

Equillium

is a California-based biotechnology firm that develops and commercializes immune-modifying therapeutics for the treatment of autoimmune and inflammatory disorders... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Equillium

is a California-based biotechnology firm that develops and commercializes immune-modifying therapeutics for the treatment of autoimmune and inflammatory disorders... Read more
Equillium President & CEO: Bruce D. Steel

President & CEO

Bruce D. Steel

CEO Approval Rating

90/100

2017

PublicNASDAQEQ

Pharmaceuticals & Biotechnology
Biotechnology
8090 NAICS listing

Annual Revenue
$41.1M
Employees
40
Funding
$95M
Acquisitions
1

News

Conference Presentation
Nov 13, 2024
Benzinga
Equillium to Present at the Stifel Healthcare Conference

Equillium Competitors

1CSL Behring
2Incyte
3Humanigen
4ElsaLys Biotech
5MaaT Pharma
6AltruBio
7Xenikos
8Affimed
9Noxxon Pharma
10Novartis
Unlock 19 + competitors

Trending Companies